Malignant peritoneal mesothelioma: A multicenter study on 81 cases

Annals of Oncology

Volumn 21, Issue 2, 2010, Pages 348-353

  de Pangher Manzini, V ^a   Recchia, L ^a   Cafferata, M ^b   Porta, C ^c   Siena, S ^d   Giannetta, L ^d   Morelli, F ^e   Oniga, F ^f   Bearz, A ^g   Torri, V ^h   Cinquini, M ^h  

^a Monfalcone Hospital   (Italy)

^b Casale Monferrato Hospital   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d OSPEDALE NIGUARDA CA GRANDA   (Italy)

^e CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^f Venice Mestre Hospital   (Italy)

^g CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^h MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Asbestos; Diagnosis; Mesothelioma; Peritoneum; Prognosis; Thrombocytosis

Indexed keywords

CARBOPLATIN; CISPLATIN; GEMCITABINE; PEMETREXED; ASBESTOS;

ABDOMINAL MASS; ABDOMINAL PAIN; ADULT; AGED; ANOREXIA; ARTICLE; ASCITES; ASTHENIA; BLADDER CARCINOMA; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DISEASE ASSOCIATION; ECHOTOMOGRAPHY; FEMALE; FEVER; HUMAN; LAPAROSCOPY; LAPAROTOMY; MAJOR CLINICAL STUDY; MALE; PERITONEAL FLUID; PERITONEUM MESOTHELIOMA; PRIORITY JOURNAL; SEMINOMA; SURVIVAL TIME; THROMBOCYTOSIS; THYROID CARCINOMA; TONGUE CARCINOMA; TUMOR DIAGNOSIS; VOMITING; WEIGHT REDUCTION; CLINICAL TRIAL; COMORBIDITY; EVALUATION; ITALY; MESOTHELIOMA; MIDDLE AGED; MULTICENTER STUDY; PERITONEUM TUMOR; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ASBESTOS; COMORBIDITY; FEMALE; HUMANS; ITALY; MALE; MESOTHELIOMA; MIDDLE AGED; PERITONEAL NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77951893959     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdp307     Document Type: Article

References (30)

1. Price B, Ware A. Mesothelioma trends in the United States: an update based on surveillance, epidemiology, and end results program data from 1973 through 2003. Am J Epidemiol 2004; 159: 107-112.
2. Bianchi C, Bianchi T. Malignant mesothelioma of the peritoneum and heavy exposure to asbestos. Eur J Oncol 2007; 12: 255-258.
3. Acherman YIZ, Welch LS, Bromley CM, Sugarbaker PH. Clinical presentation of peritoneal mesothelioma. Tumori 2003; 89: 269-273.
4. Boffetta P. Epidemiology of peritoneal mesothelioma: a review. Ann Oncol 2007; 18: 985-990.
5. Antman K, Hassan R, Eisner M et al. Update on malignant mesothelioma. Oncology 2005; 19(10): 1301-1309.
6. Yan TD, Hassan R, Welch L, Sugarbaker PH. Advances in diffuse malignant peritoneal mesothelioma. Oncol Rev 2007; 1: 53-64.
7. Yan TD, Welch L, Black D, Sugarbaker PH. A systemic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma. Ann Oncol 2006; 18(5): 827-834.
8. Deraco M, Nonaka D, Baratti D et al. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion. Ann Surg Oncol 2006; 13: 229-237.
9. Yan TD, Popa E, Brun EA et al. Sex difference in diffuse malignant peritoneal mesothelioma. Br J Surg 2006; 93(12): 1536-1542.
10. de Pangher Manzini V. Malignant peritoneal mesothelioma. Tumori 2005; 91: 1-5.
11. Kerrigan SA, Turnnir RT, Clement PB et al. Diffuse malignant epithelial mesotheliomas of the peritoneum in women: a clinicopathologic study of 25 patients. Cancer 2002; 94: 378-385.
12. Eltabbak GH, Piver MS, Hempling RE et al. Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma. J Surg Oncol 1999; 70: 6-12.
13. Sugarbaker PH, Acherman YIZ, Gonzales-Moreno S et al. Diagnosis and treatment of peritoneal mesothelioma: the Washington Cancer Institute experience. Semin Oncol 2002; 29: 51-61.
14. Patel NP, Taylor CA, Levine EA et al. Cytomorphologic features of primary peritoneal mesothelioma in effusion, washing, and fine-needle aspiration biopsy specimen: examination of 49 cases at one institution, including postintraperitoneal hyperthermic chemotherapy findings. Am J Clin Pathol 2007; 128(3): 414-422.
15. Pomjanski N, Grote HJ, Sander O et al. Early cytological diagnosis of diffuse malignant mesothelioma of the peritoneum: a case report. Diagn Cytopathol 2008; 36: 120-123.
16. de Pangher Manzini V, Brollo A, Bianchi C. Thrombocytosis in malignant pleural mesothelioma. Tumori 1990; 76: 576-578.
17. Hassan R, Alexander R, Antman K et al. Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference. Ann Oncol 2006; 17(11): 1615-1619.
18. Feldman AL, Ributti SK, Pingpank JF et al. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J Clin Oncol 2003; 21: 4560-4567.
19. Asensio JA, Goldblatt P, Thomford NR. Primary malignant peritoneal mesothelioma. A report of seven cases and a review of the literature. Arch Surg 1990; 125: 1477-1481.
20. Kannerstein M, Churg J. Peritoneal mesothelioma. Hum Pathol 1977; 8: 83-94.
21. Bianchi C, Grandi G, Di Bonito L. Mesotelioma diffuso del peritoneo ed esposizione all'asbesto. Considerazioni su due casi. Pathologica 1976; 68: 9-16.
22. Jatzko GR, Jester J. Simultaneous occurrence of a rectal carcinoma and diffuse well differentiated papillary mesothelioma of the peritoneum. Int J Colorectal Dis 1997; 12: 326-328.
23. de Pangher Manzini V, Foghin L, Thomann B. Mesotelioma maligno primitivo del peritoneo: descrizione di un caso a rapida evoluzione associato ad un adenocarcinoma del retto. Eur J Oncol 2002; 7: 63-65.
24. Argouarch LP, Borel B, Justum AM et al. Mésothéliome primitif du péritoine et exposition à l'amiante. Méd Chir Dig 1981; 10: 583-586.
25. Bani-Hani KE, Gharaibeh KA. Malignant peritoneal mesothelioma. J Surg Oncol 2005; 91: 17-25.
26. Botte G, Saro O, Preda F. Malignant peritoneal mesothelioma. Tumori 1982; 68: 91-94.
27. Piccigallo E, Jeffers LJ, Reddy R et al. Malignant peritoneal mesothelioma. A clinical and laparoscopic study on ten cases. Dig Dis Sci 1988; 5: 633-639.
28. van Gelder T, Hoogsteden HC, Versnel MA et al. Malignant peritoneal mesothelioma: a series of 19 cases. Digestion 1989; 43: 222-227.
29. Cerruto CA, Brun EA, Chang D, Sugarbaker PH. Prognostic significance of histomorphologic parameters in diffuse malignant peritoneal mesothelioma. Arch Pathol Lab Med 2006; 130: 1654-1661.
30. Yan DT, Brun EA, Cerruto CA et al. Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma. Ann Surg Oncol 2007; 14: 41-49.